Compare Crescent Energy Company Class A Common Stock (CRGY) vs Immunovant Inc. Common Stock (IMVT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Crescent Energy Company Class A Common Stock vs Immunovant Inc. Common Stock — how do they compare? Crescent Energy Company Class A Common Stock trades at $12.85 (market cap $4.30B), while Immunovant Inc. Common Stock trades at $30.49 (market cap $6.25B). The key difference: Immunovant Inc. Common Stock is the larger of the two by market cap, and Crescent Energy Company Class A Common Stock pays a 3.69% dividend while Immunovant Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Crescent Energy Company Class A Common Stock for 0 Days and Immunovant Inc. Common Stock for 0 Days on average.
| CRGY | IMVT | |
|---|---|---|
Market Cap | $4.30B | $6.25B |
Volume | 15,201,625 | 1,755,411 |
Sector | Energy | Health |
52-Week High | $15.37 | $44.96 |
52-Week Low | $7.75 | $17.03 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $9.31B | $5.35B |
Dividend Yield | 3.69% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Crescent Energy Company Class A Common Stock
Crescent Energy acquires, develops, and produces oil and natural gas from onshore U.S. basins. Its portfolio includes producing assets with oil and natural gas exposure.
Read more on CRGY →About Immunovant Inc. Common Stock
Immunovant is a clinical-stage immunology company developing therapies for autoimmune diseases. Its pipeline includes anti-FcRn antibody candidates designed for subcutaneous administration.
Read more on IMVT →
